aminoimidazole carboxamide has been researched along with lipoteichoic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoogendijk, AJ; Pinhanços, SS; van der Poll, T; Wieland, CW | 1 |
1 other study(ies) available for aminoimidazole carboxamide and lipoteichoic acid
Article | Year |
---|---|
AMP-activated protein kinase activation by 5-aminoimidazole-4-carbox-amide-1-β-D-ribofuranoside (AICAR) reduces lipoteichoic acid-induced lung inflammation.
Topics: Acetyl-CoA Carboxylase; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blotting, Western; Bronchoalveolar Lavage Fluid; Cell Line; Chemokines; Enzyme Activation; Female; Hypoglycemic Agents; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Neutrophils; Phosphorylation; Pneumonia; Ribonucleotides; Teichoic Acids; Tumor Necrosis Factor-alpha | 2013 |